Israel’s Restore Medical (see here previously) has been granted Breakthrough Device Designation by the U.S. FDA for its transcatheter Pulmonary Artery Banding (PAB) system designed for patients suffering from left ventricle failure who currently have limited treatment options. https://www.ajmc.com/view/fda-grants-breakthrough-device-designation-to-contraband-system-to-treat-hfref

Israel’s Restore Medical (see here previously) been awarded a €2.5 million grant by the European Innovation Council (EIC). Restore Medical is conducting human trials of its ContraBand implant to treat Congestive heart failure. 1,093 global companies applied for EIC funds; … Continue reading →

Israel’s Restore Medical develops the ContraBand implant that uses the patient’s Left Ventrical to assist a failing Right Ventrical for the treatment of congestive heart failure (CHF). It has just announced promising preliminary results of its First-in-Human clinical trials. https://www.israelhayom.com/2021/12/01/israels-restore-medical-announces-first-in-human-trial-of-heart-failure-treatment/ … Continue reading →